Skip to main content

2024 PharmSci 360 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Qi Zhang, Ph.D.

Lead Pharmacologist
US Food and Drug Administration

Poster(s):

(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions

Tuesday, October 22, 2024
12:30 PM – 1:30 PM MT